Y-90-Mx-DTPA-cT84.66

N/A

Report date: 2025/09/15 20:01:49

Base Information

Drug NameY-90-Mx-DTPA-cT84.66

Drug Alias NameY-90 cT84.66yttrium Y 90 anti-CEA monoclonal antibody cT84.66

ClassificationRadiation-emitting products > Nuclides > Yttrium > 90YRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive therapeutic agent +[4]

Mechanisms of ActionAnti-CEA

TargetsCarcinoembryonic antigen

Therapy Area/IndicationsLung NeoplasmsLiver NeoplasmsRectal Neoplasms +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCity Of Hope National Medical Center

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCity Of Hope National Medical Center

Active IndicationsN/A

Inactive IndicationsLung NeoplasmsLiver NeoplasmsRectal Neoplasms +[4]

Other Information

ATC CodeN/A